Opus Genetics News and Activities

Opus Genetics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Opus Genetics is a company listed under the stock ticker IRD (US).

View the org chart displaying its 19 main executives

Most searched biographies at Opus Genetics

• George Magrath, Chief Executive Officer
• Sean Ainsworth, Director
• Susan Benton, Director

Popular executive movements at Opus Genetics

• Peter Catalano has joined the company as Vice President of Accounting  (posted on November 28 2025).

Create your alert
to follow the executive moves at Opus Genetics.

Opus Genetics has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Opus Genetics

Social media about Opus Genetics

• Opus Genetics on Wikipedia, Google News & Yahoo Finance
• Opus Genetics on LinkedIn, X (Twitter) & YouTube